Cefazolin Dialysis Removal
Yes, cefazolin is significantly removed by hemodialysis, with approximately 40-50% of the drug cleared during a typical dialysis session, requiring supplemental dosing after dialysis.
Dialysis Clearance and Pharmacokinetics
Cefazolin undergoes substantial removal during hemodialysis due to its pharmacokinetic properties. The drug exhibits dramatically different half-lives depending on dialysis status:
- Intradialysis half-life: 2.3-4.05 hours 1, 2
- Interdialysis half-life: 26-32 hours 1, 3, 2
- Dialysis clearance: 1.95 L/h (compared to interdialysis clearance of 0.16 L/h) 1
- Percentage removed per session: 41-53% 1, 2
The FDA label confirms that cefazolin is excreted unchanged in the urine (60% in first 6 hours, 70-80% within 24 hours in patients with normal renal function), making it highly susceptible to removal by dialysis 4.
Recommended Dosing for Hemodialysis Patients
The IDSA guidelines provide clear, evidence-based dosing recommendations for hemodialysis patients 5:
- Dose: 20 mg/kg (actual body weight), rounded to the nearest 500-mg increment
- Timing: Administer after each dialysis session
- Standard dose: Typically 1 g IV post-dialysis (750 mg for patients <50 kg) 3
This post-dialysis dosing strategy is critical because:
- It prevents premature drug removal during dialysis
- It facilitates directly observed therapy (three times per week dosing)
- It maintains therapeutic concentrations throughout the interdialytic period 6
Clinical Efficacy in Dialysis Patients
The recommended 1 g IV post-dialysis dosing achieves:
- Total serum drug concentrations >40 mg/L in all patients 1
- This concentration exceeds the threshold required for bactericidal activity against Staphylococcus species
- Therapeutic levels are maintained throughout dialysis after a single 500 mg dose 7
Cefazolin is equivalent to vancomycin for empiric treatment of clinically significant infections in hemodialysis patients with low rates of methicillin-resistant S. aureus 3. The IDSA specifically recommends switching from empirical vancomycin to cefazolin when methicillin-susceptible S. aureus is identified 5.
Peritoneal Dialysis Considerations
For peritoneal dialysis, cefazolin behaves differently:
- Peritoneal dialysis half-life: 32.1 hours 2
- Minimal removal occurs with peritoneal dialysis 2, 8
- No supplemental dosing required after peritoneal dialysis 2
- Intraperitoneal administration produces mean serum levels of 10-30 mcg/mL after 24 hours with dialysate concentrations of 50-150 mg/L 4
Important Clinical Caveats
Hemodialysis removes cefazolin significantly more efficiently than peritoneal dialysis due to differences in clearance mechanisms 2, 8. The degree of removal during hemodialysis varies with:
- Dialysate flow rate (decreased flow = decreased removal) 2
- Membrane surface area (smaller area = decreased removal) 2
- Protein binding status, which varies with degree of azotemia 7
Common pitfall: Failing to administer supplemental doses after hemodialysis leads to subtherapeutic levels and treatment failure. The interdialytic half-life of 26-32 hours means that without post-dialysis dosing, drug concentrations will fall below therapeutic thresholds before the next dialysis session 1, 3.